Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines
- PMID: 20442687
- PMCID: PMC3704726
- DOI: 10.1097/INF.0b013e3181e232ea
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines
Abstract
Background: Live oral rotavirus vaccines have been less immunogenic and efficacious among children in poor developing countries compared with middle income and industrialized countries for reasons that are not yet completely understood. We assessed whether the neutralizing activity of breast milk could lower the titer of vaccine virus and explain this difference in vitro.
Methods: Breast milk samples were collected from mothers who were breast-feeding infants 4 to 29 weeks of age (ie, vaccine eligible age) in India (N = 40), Vietnam (N = 77), South Korea (N = 34), and the United States (N = 51). We examined breast milk for rotavirus-specific IgA and neutralizing activity against 3 rotavirus vaccine strains-RV1, RV5 G1, and 116E using enzyme immunoassays. The inhibitory effect of breast milk on RV1 was further examined by a plaque reduction assay.
Findings: Breast milk from Indian women had the highest IgA and neutralizing titers against all 3 vaccine strains, while lower but comparable median IgA and neutralizing titers were detected in breast milk from Korean and Vietnamese women, and the lowest titers were seen in American women. Neutralizing activity was greatest against the 2 vaccine strains of human origin, RV1 and 116E. This neutralizing activity in one half of the breast milk specimens from Indian women could reduce the effective titer of RV1 by ∼2 logs, of 116E by 1.5 logs, and RV5 G1 strain by ∼1 log more than that of breast milk from American women.
Interpretation: The lower immunogenicity and efficacy of rotavirus vaccines in poor developing countries could be explained, in part, by higher titers of IgA and neutralizing activity in breast milk consumed by their infants at the time of immunization that could effectively reduce the potency of the vaccine. Strategies to overcome this negative effect, such as delaying breast-feeding at the time of immunization, should be evaluated.
Figures


Similar articles
-
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries.Pediatr Infect Dis J. 2013 Aug;32(8):863-70. doi: 10.1097/INF.0b013e318290646d. Pediatr Infect Dis J. 2013. PMID: 23584581 Free PMC article.
-
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.Clin Infect Dis. 2016 Jan 15;62(2):157-65. doi: 10.1093/cid/civ828. Epub 2015 Sep 23. Clin Infect Dis. 2016. PMID: 26400993
-
Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines.Hum Vaccin Immunother. 2014;10(12):3681-7. doi: 10.4161/21645515.2014.980204. Hum Vaccin Immunother. 2014. PMID: 25668672 Free PMC article.
-
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy.J Infect Dis. 2013 Jul 15;208(2):284-94. doi: 10.1093/infdis/jit166. Epub 2013 Apr 17. J Infect Dis. 2013. PMID: 23596320
-
Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis.Pediatr Infect Dis J. 2021 Dec 1;40(12):1135-1143. doi: 10.1097/INF.0000000000003286. Pediatr Infect Dis J. 2021. PMID: 34870393 Free PMC article.
Cited by
-
Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.Mucosal Immunol. 2015 Jan;8(1):1-17. doi: 10.1038/mi.2014.114. Epub 2014 Dec 3. Mucosal Immunol. 2015. PMID: 25465100 Review.
-
Rotavirus immune responses and correlates of protection.Curr Opin Virol. 2012 Aug;2(4):419-25. doi: 10.1016/j.coviro.2012.05.003. Epub 2012 Jun 5. Curr Opin Virol. 2012. PMID: 22677178 Free PMC article. Review.
-
Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa.PLoS One. 2014 Sep 30;9(9):e105167. doi: 10.1371/journal.pone.0105167. eCollection 2014. PLoS One. 2014. PMID: 25268783 Free PMC article.
-
Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India.J Virol. 2014 Aug;88(16):9060-71. doi: 10.1128/JVI.01417-14. Epub 2014 Jun 4. J Virol. 2014. PMID: 24899175 Free PMC article.
-
Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.Malawi Med J. 2017 Mar;29(1):24-28. doi: 10.4314/mmj.v29i1.5. Malawi Med J. 2017. PMID: 28567192 Free PMC article.
References
-
- World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285–295. - PubMed
-
- Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. - PubMed
-
- Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. - PubMed
-
- Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J. 2004;23:937–943. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous